Impact of COVID-19 Pandemic on Initiation of Immunosuppressive Treatment in Immune-Mediated Inflammatory Diseases in Austria: A Nationwide Retrospective Study

Objective: Conventional immunosuppressive and advanced targeted therapies, including biological medications and small molecules, are a mainstay in the treatment of immune-mediated inflammatory diseases (IMID). However, the COVID-19 pandemic caused concerns over these drugs’ safety regarding the risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Kutschera, Maximilian, Ritschl, Valentin, Reichardt, Berthold, Stamm, Tanja, Kiener, Hans, Maier, Harald, Reinisch, Walter, Benka, Bernhard, Novacek, Gottfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503597/
https://www.ncbi.nlm.nih.gov/pubmed/36142955
http://dx.doi.org/10.3390/jcm11185308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9503597/
https://www.ncbi.nlm.nih.gov/pubmed/36142955
http://dx.doi.org/10.3390/jcm11185308

Ejemplares similares